SAGE Therapeutics, Inc. (SAGE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1236362,
    "name": "SAGE Therapeutics, Inc.",
    "stock_name": "SAGE Therapeutics, Inc.",
    "full_name": "SAGE Therapeutics, Inc.",
    "name_url": "stocks-analysis/sage-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "8.68",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "8.68",
    "mcapval": "533.65",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US78667J1088",
    "curr_date": "Aug 01",
    "curr_time": "",
    "bse_nse_vol": "0 ",
    "exc_status": "Active",
    "traded_date": "Aug 01, 2025",
    "traded_date_str": "2025 08 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sage-therapeutics-inc-1236362-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is SAGE Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sage-therapeutics-inc-technically-bullish-or-bearish-3547314",
        "imagepath": "",
        "date": "2025-09-20 19:52:34",
        "description": "As of 18 July 2025, the technical trend for SAGE Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. However, the weekly RSI is bearish, indicating some weakness in momentum. The Bollinger Bands show a mildly bullish stance on the weekly chart but are mildly bearish on the monthly chart. Moving averages are bullish on the daily timeframe, while the KST is bullish weekly and mildly bullish monthly. Dow Theory indicates a bearish stance on both weekly and monthly timeframes. The On-Balance Volume is mildly bearish weekly with no trend monthly.\n\nIn terms of performance, SAGE has underperformed the S&P 500 over the past week and month, with returns of -1.36% and -4.41% compared to 1.05% and 2.33% for the index, respectively. However, year-to-date, SAGE has significantly outperformed the S&P 500 with a return of 59.85% versus 12.22%..."
      },
      {
        "title": "Is SAGE Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sage-therapeutics-inc-overvalued-or-undervalued-3543714",
        "imagepath": "",
        "date": "2025-09-20 18:26:41",
        "description": "As of 24 February 2022, the valuation grade for SAGE Therapeutics, Inc. has moved from attractive to risky, indicating a significant deterioration in its financial outlook. The company appears to be overvalued given its current financial metrics, particularly with a price-to-book ratio of 1.05 and a negative return on equity of -81.01%. Additionally, the EV to EBITDA ratio stands at -0.02, further highlighting the company's struggles.\n\nWhen compared to its peer, Ironwood Pharmaceuticals, Inc., which has a P/E ratio of 13.85 and an EV to EBITDA of 6.53, SAGE's metrics suggest it is not performing favorably within its industry. The stock has underperformed against the S&P 500 over the past year, with a return of -11.07% compared to the index's 17.14%, reinforcing the notion that SAGE is currently overvalued...."
      }
    ],
    "total": 6,
    "sid": "1236362",
    "stock_news_url": "https://www.marketsmojo.com/news/sage-therapeutics-inc-1236362"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is SAGE Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:52:34

As of 18 July 2025, the technical trend for SAGE Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. However, the weekly RSI is bearish, indicating some weakness in momentum. The Bollinger Bands show a mildly bullish stance on the weekly chart but are mildly bearish on the monthly chart. Moving averages are bullish on the daily timeframe, while the KST is bullish weekly and mildly bullish monthly. Dow Theory indicates a bearish stance on both weekly and monthly timeframes. The On-Balance Volume is mildly bearish weekly with no trend monthly. In terms of performance, SAGE has underperformed the S&P 500 over the past week and month, with returns of -1.36% and -4.41% compared to 1.05% and 2.33% for the index, respectively. However, year-to-date, SAGE has significantly outperformed the S&P 500 with a return of 59.85% versus 12.22%...

Is SAGE Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:26:41

As of 24 February 2022, the valuation grade for SAGE Therapeutics, Inc. has moved from attractive to risky, indicating a significant deterioration in its financial outlook. The company appears to be overvalued given its current financial metrics, particularly with a price-to-book ratio of 1.05 and a negative return on equity of -81.01%. Additionally, the EV to EBITDA ratio stands at -0.02, further highlighting the company's struggles. When compared to its peer, Ironwood Pharmaceuticals, Inc., which has a P/E ratio of 13.85 and an EV to EBITDA of 6.53, SAGE's metrics suggest it is not performing favorably within its industry. The stock has underperformed against the S&P 500 over the past year, with a return of -11.07% compared to the index's 17.14%, reinforcing the notion that SAGE is currently overvalued....

View All News